Analyst Concerns On Vertex's Approved Drug
June 25, 2014 at 09:14 AM EDT
HC Wainwright cut its rating on Vertex Pharmaceuticals (NASDAQ: VRTX) to Neutral after the stock rallied nearly 50 percent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.